Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-33.33%)
Aug 19, 2026, 2:36 PM EST
Regen BioPharma Market Cap
Regen BioPharma has a market cap or net worth of $156.53 thousand as of August 19, 2026. Its market cap has decreased by -87.48% in one year.
Market Cap
156.53K
Enterprise Value
1.06M
Revenue
236.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since September 4, 2014, Regen BioPharma's market cap has decreased from 19.72M to 156.53K, a decrease of -99.21%. That is a compound annual growth rate of -33.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 156.53K | -80.42% |
| Dec 31, 2025 | 799.61K | -47.23% |
| Dec 31, 2024 | 1.52M | -57.47% |
| Dec 29, 2023 | 3.56M | -81.90% |
| Dec 30, 2022 | 19.69M | -70.55% |
| Dec 31, 2021 | 66.86M | 9,040.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RegeneRx Biopharmaceuticals | 260.99K |
| CNBX Pharmaceuticals | 240.87K |
| Ocean Biomedical | 232.37K |
| GB Sciences | 211.76K |
| Ampio Pharmaceuticals | 207.88K |
| Endonovo Therapeutics | 180.76K |
| Innovation Pharmaceuticals | 158.63K |
| IO Biotech | 143.90K |